Though loss of function in CBP/p300, a family of CREB-binding proteins, has been causally associated with a variety of human neurological disorders, such as Rubinstein-Taybi syndrome, Huntington's disease and drug addiction, the role of EP300 interacting inhibitor of differentiation 1 (EID1), a CBP/p300 inhibitory protein, in modulating neurological functions remains completely unknown. Through the examination of EID1 expression and cellular distribution, we discovered that there is a significant increase of EID1 nuclear translocation in the cortical neurons of Alzheimer's disease (AD) patient brains compared to that of control brains. To study the potential effects of EID1 on neurological functions associated with learning and memory, we generated a transgenic mouse model with a neuron-specific expression of human EID1 gene in the brain. Overexpression of EID1 led to an increase in its nuclear localization in neurons mimicking that seen in human AD brains. The transgenic mice had a disrupted neurofilament organization and increase of astrogliosis in the cortex and hippocampus. Furthermore, we demonstrated that overexpression of EID1 reduced hippocampal long-term potentiation and impaired spatial learning and memory function in the transgenic mice. Our results indicated that the negative effects of extra nuclear EID1 in transgenic mouse brains are likely due to its inhibitory function on CBP/p300 mediated histone and p53 acetylation, thus affecting the expression of downstream genes involved in the maintenance of neuronal structure and function. Together, our data raise the possibility that alteration of EID1 expression, particularly the increase of EID1 nuclear localization that inhibits CBP/p300 activity in neuronal cells, may play an important role in AD pathogenesis.
Introduction
EID1 (EP300 interacting inhibitor of differentiation 1), also known as CRI1, was originally identified as a pRb-interacting protein negatively regulates myogenesis (MacLellan et al., 2000; Miyake et al., 2000) . EID1 inhibits myogenic differentiation by blocking the histone acetyltransferase (HAT) activity of p300/CREB (cAMP response element binding protein) binding protein, a transcriptional coactivator, required for MyoD dependent transactivation. Its physical interaction with pRb brings EID1 to MDM2, an E3 ubiquitin ligase, leading to its proteasomal degradation up on cell cycle exit. In contrast, its interaction with the RET finger protein (RFP, TRIM 27), an upstream modulator of Rb, increases the stability of EID1protein thus inhibits Rb mediated transcription activation (Krutzfeldt et al., 2005) . A newly identified EID1 binding partner, Necdin, antagonizes the repressive effects of EID1 whereby promotes myoblast differentiation. This interaction also stabilizes EID1 and promotes its relocalization to the cytoplasm (Bush and Wevrick, 2008) . EID1 can also be recruited and bridged by other transcriptional inhibitors, such as small heterodimer partner (SHP), which directly binds and inhibits a large set of nuclear receptors, or bind directly to nuclear receptors, such as orphan nuclear receptor, SF1, to accomplish transcriptional inhibition (Bavner et al., 2002; Macchiarulo et al., 2006; Park et al., 2007) . It is suggested that the mechanism of these transcriptional inhibitions involves EID1 antagonism of the p300/ CBP (CREB binding protein)-dependent co-activator functions (Bavner et al., 2002; Chen et al., 2005; Park et al., 2007) .
Transcriptional co-activator CBP and p300 have high degree of homology and similar pattern of expression. They both stimulate CREB-dependent gene expression by interacting with and integrating a variety of signal-responsive transcription factors, modifying transcription factors and histone by acetylation (Vo and Goodman,
